APOGEE THERAPEUTICS
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders. The company aims to advance novel therapies to address patients’ needs. Based in San Francisco, California, Apogee Therapeutics was founded in 2022.
APOGEE THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Medical Therapeutics
Founded:
2022-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.apogeetherapeutics.com
Total Employee:
101+
Status:
Active
Total Funding:
652 M USD
Technology used in webpage:
Google Maps Amazon IPv6 U.S. Server Location Google Maps API Amazon Virginia Region CloudFront GoDaddy SSL Akamai Hosted Equinix
Similar Organizations
Affinia Therapeutics
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Nuvalent
Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer.
Prime Medicine
Prime Medicine operates as a biotechnology company that delivers the promise of gene editing using Prime Editing.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
RTW Investments
RTW Investments investment in Series B - Apogee Therapeutics
Fidelity
Fidelity investment in Series B - Apogee Therapeutics
Deep Track Capital
Deep Track Capital investment in Series B - Apogee Therapeutics
Wellington Management
Wellington Management investment in Series B - Apogee Therapeutics
OrbiMed
OrbiMed investment in Series B - Apogee Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series B - Apogee Therapeutics
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series B - Apogee Therapeutics
Fairmount Funds Management
Fairmount Funds Management investment in Series B - Apogee Therapeutics
RA Capital Management
RA Capital Management investment in Series B - Apogee Therapeutics
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series A - Apogee Therapeutics
Key Employee Changes
Official Site Inspections
http://www.apogeetherapeutics.com Semrush global rank: 5.38 M Semrush visits lastest month: 1.4 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Apogee Therapeutics"
Contact - Apogee Therapeutics
Apogee Therapeutics is a clinical stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and …See details»
Apogee Therapeutics - Crunchbase Company Profile
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders. The company aims to advance …See details»
Investor Relations | Apogee Therapeutics, Inc.
Apogee Therapeutics Announces Positive Interim Phase 1 Results from the APG990 Healthy Volunteer Trial, Unlocking Potential Maintenance Dosing Every Three and Six Months for …See details»
APGE - Apogee Therapeutics, Inc. | Company Profile | OTC Markets
6 days ago apogeetherapeutics.com (650) 394-5230. [email protected]. Business Description. Apogee Therapeutics, Inc., through its subsidiary, operates as a …See details»
Apogee Therapeutics - LinkedIn
Apogee Therapeutics | 19,585 followers on LinkedIn. Apogee Therapeutics, LLC is a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the millions of ...See details»
Apogee Therapeutics - Overview, News & Similar companies
Apogee Therapeutics contact info: Phone number: (650) 394-5230 Website: www.apogeetherapeutics.com What does Apogee Therapeutics do? Apogee Therapeutics, …See details»
Apogee Therapeutics - Company Profile - Tracxn
Feb 24, 2025 Apogee Therapeutics - Developer of therapeutics for immunological and inflammatory disorders. Public Company. Raised a total funding of $149M over 1 round from 7 …See details»
Apogee Therapeutics, Inc. - Drug pipelines, Patents, Clinical
Investor Contact:Noel KurdiVP, Investor Relations Apogee Therapeutics, [email protected] Media Contact:Dan Budwick 1AB …See details»
Apogee Therapeutics Provides Pipeline Progress and Reports Full …
Mar 3, 2025 For more information, please visit https://apogeetherapeutics.com. Forward Looking Statements. Certain statements in this press release may constitute “forward-looking …See details»
Apogee Therapeutics | Meet the People that Power Progress
Apogee Therapeutics is a clinical stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), …See details»
Release Details - investors.apogeetherapeutics.com
For more information, please visit https://apogeetherapeutics.com. Forward Looking Statements Certain statements in this press release may constitute “forward-looking statements” within the …See details»
Apogee Therapeutics - PitchBook
Apogee Therapeutics General Information Description. Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic …See details»
Our Science - Apogee Therapeutics
Mar 3, 2025 Our goal is to discover and develop novel therapies for a range of I&I diseases. We aim to accomplish this goal by focusing on known biologic drivers of disease and utilizing …See details»
Apogee Therapeutics Launches with $169 Million to Develop …
Dec 7, 2022 Apogee Therapeutics, LLC is a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the millions of people living with immunological …See details»
Apogee Therapeutics Launches with $169 Million to Develop
Dec 7, 2022 To learn more visit www.apogeetherapeutics.com. About Paragon Therapeutics. Paragon Therapeutics, Inc. is a biotechnology company leveraging cutting-edge science and …See details»
Apogee Therapeutics to Participate in Upcoming March Investor …
Feb 25, 2025 SAN FRANCISCO and BOSTON, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE) today announced that members of management will …See details»
Apogee Therapeutics Provides Pipeline Progress and Reports
Dec 11, 2024 apogee therapeutics, inc. condensed consolidated statement of operations (unaudited) (in thousands) three months endedSee details»
Release Details - investors.apogeetherapeutics.com
Mar 3, 2025 Interim Phase 1 results for APG990, a novel half-life extended OX40L antibody, exceeded trial objectives and demonstrated an approximately 60-day half-life APG279 …See details»
Apogee Therapeutics Highlights Progress and Best-in-Class …
Dec 2, 2024 Positive interim Phase 1 data indicate APG808 was well-tolerated with half-life of approximately 55 days, supporting potential for 2- to 3- month dosing and demonstrating deep …See details»
Release Details - investors.apogeetherapeutics.com
Dec 2, 2024 Positive interim Phase 1 data indicate APG808 was well-tolerated with half-life of approximately 55 days, supporting potential for 2- to 3- month dosing and demonstrating deep …See details»